Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
复制标题
DOI：
10.1172/jci200114120
复制
发表时间：
2001-12-01
影响因子：
15.9
通讯作者：
Rossetti, L
中科院分区：
文献类型：
--
作者：
Combs, TP;Berg, AH;Rossetti, L
腹腔注射纯化的重组 Acrp30 可降低小鼠的葡萄糖水平。为了深入了解这种降血糖作用的机制，在胰腺正常血糖钳夹过程中将纯化的重组 Acrp30 注入清醒的小鼠体内。在存在生理性高胰岛素血症的情况下，这种治疗使循环 Acrp30 水平增加约两倍并刺激葡萄糖代谢。 Acrp30 对体内胰岛素作用的影响完全是由于葡萄糖生成率降低了 65%。同样，通过葡萄糖-6-磷酸酶 (G6Pase) 的葡萄糖通量随着 Acrp30 的增加而减少，而葡萄糖-6-磷酸生物合成的直接途径（肝葡萄糖磷酸化的指标）的活性显着增加。 Acrp30 不影响葡萄糖摄取、糖酵解或糖原合成的速率。这些结果表明，循环 Acrp30 水平的急剧增加会降低肝脏葡萄糖的产生，而不影响外周葡萄糖的摄取。与输注载体相比，输注 Acrp30 后糖异生酶磷酸烯醇丙酮酸羧激酶和 G6Pase mRNA 的肝脏表达减少了 50% 以上。因此，脂肪源性蛋白 Acrp30 循环水平的适度升高会抑制肝糖异生酶的表达和内源性葡萄糖产生的速率。
Intraperitoneal injection of purified recombinant Acrp30 lowers glucose levels in mice. To gain insight into the mechanism(s) of this hypoglycemic effect, purified recombinant Acrp30 was infused in conscious mice during a pancreatic euglycemic clamp. In the presence of physiological hyperinsulinemia, this treatment increased circulating Acrp30 levels by approximately twofold and stimulated glucose metabolism. The effect of Acrp30 on in vivo insulin action was completely accounted for by a 65% reduction in the rate of glucose production. Similarly, glucose flux through glucose-6-phosphatase (G6Pase) decreased with Acrp30, whereas the activity of the direct pathway of glucose-6-phosphate biosynthesis, an index of hepatic glucose phosphorylation, increased significantly. Acrp30 did not affect the rates of glucose uptake, glycolysis, or glycogen synthesis. These results indicate that an acute increase in circulating Acrp30 levels lowers hepatic glucose production without affecting peripheral glucose uptake. Hepatic expression of the gluconeogenic enzymes phosphoenolpyruvate carboxykinase and G6Pase mRNAs was reduced by more than 50% following Acrp30 infusion compared with vehicle infusion. Thus, a moderate rise in circulating levels of the adipose-derived protein Acrp30 inhibits both the expression of hepatic gluconeogenic enzymes and the rate of endogenous glucose production.